References
- 1. Abdel–Salam O.M.E., Youness E.R., Hafez H.F.: The antioxidant status of the plasma in patients with breast cancer undergoing chemotherapy. Open J Mol Integr Physiol 2011, 1, 29–35.
- 2. Abiaka C., Al–Awadi F., Al–Sayer H., Gulshan S., Behbehani A., Farghally M.: Activities of erythrocyte antioxidant enzymes in cancer patients. J Clin Lab Anal 2002, 16, 167–171.
- 3. Bannister J.V., Bannister W.H., Rotilio G.: Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem 1987, 22, 111–180.
- 4. Brewer G.J., Aster J.S., Kuntsen C.A.: Zinc inhibition of calmodulin: proposed molecular mechanism of zinc action on cellular functions. Am J Haematol 1993, 7, 53–60.
- 5. Brodzki A., Brodzki P., Szpetnar M., Tatara M.R.: Serum concentration of free amino acids in dogs suffering from perianal tumors. Bull Vet Inst Pulawy 2013, 57, 47–52.
- 6. Brodzki A., Tatara M.R., Brodzki P.: Serum concentration of magnesium in dogs suffering from tumors of the perianal glands. Magnes Res 2013, 26, 87–92.
- 7. Brodzki A, Tatara M.R.: Copper and zinc concentration in mammary gland tumor tissue of dogs. Pol J Environ Studies 2007, 16(3A), 38–41.
- 8. Brudzińska A., Idziak M.: Tumors of perianal glands in dogs. Magazyn Wet 2008, 17, 1130–1134.
- 9. Crapo J.D., Oury T., Rabouille C., Slot J.W., Chang L.Y.: Copper, zinc superoxide dismutase is a primarily a cytosolic proein in human cells. Proc Natl Acad Sci USA 1992, 89, 10405–10409.
- 10. Fossum T.W.: Small Animal Surgery. Elsevier Urban & Partners, Wrocław, Poland, 2009.
- 11. Fridovich I.: Superoxide dismutases studies of structure and mechanism. Adv Exp Med Biol 1976, 74, 530–539.
- 12. Fridovich I.: The biology of oxygen radicals. Science 1978, 201, 875–880.
- 13. Giannatasio G.: Effect of calcium on adneylate cyclase of rat anterior pituitary gland. Endocrinology 1987, 120, 2611–2619.
- 14. Halliwell B., Gutteridge J.M.: The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995, 18, 125–126.
- 15. Heinlein C.A., Chang C.: Androgen receptor in prostate cancer. Endocr Rev 2004, 25, 276–308.
- 16. Kensler T.W., Trush M.A.: Role of oxygen radicals in tumor promotion. Environ Mutagen 1984, 6, 593–616.
- 17. Kumaraguruparan R., Subapriya R., Kabalimoorthy J., Nagini S.: Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002, 35, 275–279.
- 18. Liczmański A.E.: Oxygen toxicity. I. Damage of living cells. Postepy Biochem 1988, 34, 273–291.
- 19. Ma E.L., Jiang Z.M.: Iron exchange chromatography in simultaneous determination of serum cooper and zinc levels in patients with cancer of digestive tract. Chin Med J 1993, 2, 118–121.
- 20. Munro H.N., Linder M.C.: Ferritin: structure, biosynthesis and role in iron metabolism. Physiol Rev 1978, 58, 317–319.
- 21. Musik I., Kiełczykowska M., Kocot J.: Comparison of the influence of selenium supplementation in organic and inorganic forms on oxidant/antioxidant balance in rat lungs. Bull Vet Inst Pulawy 2013, 57, 449–453.
- 22. Musik I., Kiełczykowska M.: Influence of different forms of selenium supplementation on the oxidant balance in the rat liver. Med Weter 2013, 69, 415–419.
- 23. Queiroga F.L., Pérez–Alenza M.D., Silvan G., Peña L., Lopes C., Illera J.C.: Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol 2005, 94, 181–187.
- 24. Rabovsky A.B., Komarov A.M., Ivie J.S., Buettner G.R.: Minimization of free radical damage by metal catalysis of multivitamin/multimineral supplements. Nutr J 2010, 9, 61.
- 25. Sawaki M., Enomato K., Hattori A., Tsuzuki N., Sugawara N., Mori M.: Role of cooper accumulation and metallothionein induction in spontaneous liver cancer development in LEC rats. Carcinogenesis 1994, 15, 1833–1837.
- 26. Singh K.P., Zaidi S., Raissudin S., Saxena A.K., Murthy R.C., Ray P.K.: Effect of zinc immune functions and host resistance against infection and tumor challenge. Immunopharmacol Immunotoxicol 1992, 14, 813–840.
- 27. Szczubiał M., Kankofer M., Łopuszyński W., Dabrowski R., Lipko J.: Oxidative stress parameters in bitches with mammary gland tumours. J Vet Med A Physiol Pathol Clin Med 2004, 51, 336–340.
- 28. Vuillaume M.: Reduced oxygen species, mutation, induction and cancer initiation. Mutat Res 1987, 186, 43–72.
- 29. Wells M.A.: Spectral perturbations of Crotalus admanteus phospholipase A2 induced by divalent cation binding. Biochemistry 1973, 12, 1080–1085.
- 30. Yucel J., Arpaci F., Ozet A.: Serum cooper and zinc levels and cooper/zinc ratio in patients with breast cancer. Biol Trace Elem Res 1994, 1, 31–38.
- 31. Zalewski P.D., Forbes I.J., Giannakis C.: Physiological role for zinc in prevention of apoptosis (gene–directed death). Biochem Int 1991, 24, 1093–1101.
- 32. Zelko I.N., Mariani T.J., Folz R.J.: Superoxide dismutase multigene family: a comparison of the CuZn–SOD (SOD1), Mn-SOD (SOD2), and EC–SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002, 33, 337–349.
- 33. Zhang Y.J., Zhao D.H., Huang C.X.: The changes in cooper contents and its clinical significance in patients with liver cirrosis and hepatocarcinoma. Zhonghua Nei Ke Za Zhi 1994, 2, 113–116.